title: Mutations in the p53 gene occur in diverse human tumour types.
abstract: The p53 gene has been a constant source of fascination since its discovery nearly a decade ago. Originally considered to be an oncogene, several convergent lines of research have indicated that the wild-type gene product actually functions as a tumour suppressor gene. For example, expression of the neoplastic phenotype is inhibited, rather than promoted, when rat cells are transfected with the murine wild-type p53 gene together with mutant p53 genes and/or other oncogenes. Moreover, in human tumours, the short arm of chromosome 17 is often deleted. In colorectal cancers, the smallest common region of deletion is centred at 17p13.1; this region harbours the p53 gene, and in two tumours examined in detail, the remaining (non-deleted) p53 alleles were found to contain mutations. This result was provocative because allelic deletion coupled with mutation of the remaining allele is a theoretical hallmark of tumour-suppressor genes. In the present report, we have attempted to determine the generality of this observation; that is, whether tumours with allelic deletions of chromosome 17p contain mutant p53 genes in the allele that is retained. Our results suggest that (1) most tumours with such allelic deletions contain p53 point mutations resulting in amino-acid substitutions, (2) such mutations are not confined to tumours with allelic deletion, but also occur in at least some tumours that have retained both parental 17p alleles, and (3) p53 gene mutations are clustered in four 'hot-spots' which exactly coincide with the four most highly conserved regions of the gene. These results suggest that p53 mutations play a role in the development of many common human malignancies.
authors.affiliation: Johns Hopkins Oncology Center, Baltimore, Maryland 21231.
authors.forename: J M
authors.initials: JM
authors.lastname: Nigro
authors.forename: S J
authors.initials: SJ
authors.lastname: Baker
authors.forename: A C
authors.initials: AC
authors.lastname: Preisinger
authors.forename: J M
authors.initials: JM
authors.lastname: Jessup
authors.forename: R
authors.initials: R
authors.lastname: Hostetter
authors.forename: K
authors.initials: K
authors.lastname: Cleary
authors.forename: S H
authors.initials: SH
authors.lastname: Bigner
authors.forename: N
authors.initials: N
authors.lastname: Davidson
authors.forename: S
authors.initials: S
authors.lastname: Baylin
authors.forename: P
authors.initials: P
authors.lastname: Devilee
mesh_terms: D000483:Alleles; D001483:Base Sequence; D002872:Chromosome Deletion; D002886:Chromosomes, Human, Pair 17; D003001:Cloning, Molecular; D003062:Codon; D004273:DNA, Neoplasm / Q000235:genetics; D004259:DNA-Directed DNA Polymerase; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D009369:Neoplasms / Q000235:genetics*; D009456:Neurofibromatosis 1 / Q000235:genetics; D015513:Oncogene Proteins / Q000235:genetics*; D010750:Phosphoproteins / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics; D016159:Tumor Suppressor Protein p53
chemical_list: D003062:Codon; D004273:DNA, Neoplasm; D015513:Oncogene Proteins; D010750:Phosphoproteins; D012333:RNA, Messenger; D016159:Tumor Suppressor Protein p53; D004259:DNA-Directed DNA Polymerase